Pfizer is awaiting FDA approval of their male impotency drug. I believe the drug (the actual name of which escapes me) was orginally designed to reduce cardio-stress. While it didn't reduce stress, male patients had a noticed increase in sexual desire. Most notably, impotent men were able to have relations again, when without the drug they were unable. What's significant is that this drug is to be taken orally (unlike Vivex which is inserted into the urethra and has many side-effects like stinging and pain during urination, just to name a few). The drug, nicknamed the "Pfizerier" should be out by the fall. I wouldn't be selling Pfizer right now if I were you. 20 million men suffer from impotence and the market is 10 billion in sales. Hang in there for a while.
You're referring to Viagra--the new drug which should be released by the fda fairly soon. As I have stated before this should be a bonanza to Pfe. This drug is about 60 to 65% effective in erectile dysfunction. No need to resort to rhinoceros horn. By the way the mail is full of mail order products with interesting names--has anyone heard of the following. To wit: caveril;vasoGenitine which induce the production of nitric acid as a mediator for penile erection; oral phentalomil. These products are without presciption. Are they as good as the advertisements claim? Need to know.
This is a good company. When is the best time to buy is a tough one. Research the 5yr pe avaerage, look at the growth projections, look at the financial date, etc., then make your decision. Information overload may not lead to the best decision but it cannot hurt you. The more informed you are the better the decision making process.
Unless you're a trader, it's hard to figure out when it's been a bad time to buy PFE. Look at the maximum-term chart on Yahoo. It's about as good as they come. Anytime anyone has bought this stock over the past . . . I don't know . . .several decades, they've made money long term. You may be able to time a dip and save a couple of points -- not trival -- but in the long term, this is one to hold and grow with. Whether you get in now or next month won't matter in 10 years, when your base cost is $2.50/share.